LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer.

CONCLUSION: LAMC1 overexpression is a potent biomarker for identifying endometrial cancer patients needing aggressive adjuvant therapy. We elucidated 8 candidate genes that may mediate progression of LAMC1 overexpressing cancer. Further investigation of the underlying mechanism should lead to the discovery of new therapeutic targets. PMID: 31912669 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31912669?dopt=Abstract

Source: Journal of Gynecologic Oncology - January 10, 2020 Category: OBGYN Tags: J Gynecol Oncol Source Type: research